Enveda Therapeutics, Inc.
Boulder, CO · Founded 2019 · CIK 0001821392 · Biotech · Private
AI-powered drug discovery platform using natural product chemistry and machine learning to identify therapeutic compounds
enveda.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $67M
- 2 Form D · Mar 2023
- 43 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 24
- 0 granted · 24 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2020202120222023
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $4,999,998 | |
| Private capital raised | Form D · SEC | $62,459,761 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2019 | Outer Biosciences, LLC | — | $4.0M |
| 2020 | VITAKEY, INC. | — | $44M |
| 2021 | SOMATOCEUTICS, LLC | — | — |
| 2022 | Enveda Therapeutics, Inc. | — | $67M |
| 2023 | Vigil Neuroscience | — | $195M |
| 2024 | Sedare Biosciences, Inc. | — | $2.5M |
| 2025 | Sentonix, Inc. | — | $18M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Bruce BeutelDirector
- Viswa ColluruDirector · Executive Officer
- Zavain DarDirector
- Rohit SharmaDirector
- Shaquille VaydaDirector
- Daniel WeeExecutive Officer
Patents
- Methods And Systems For Identifying Compounds For Forming, Stabilizing Or Disrupting Molecular Complexesapplication
- Predicting Chemical Structure And Properties Based On Mass Spectraapplication
- Isoandrographolide Analogs And Method For Treatment Using The Sameapplication
- Mass-targeted Fractionation System With Asynchronous Dual-dimension Separationapplication
- Methods For Identifying Metabolites, And For Developing And Evaluating Therapeutic Agents Based On The Sameapplication
- Multi-omic Patient Stratification In Inflammatory Bowel Disease Treatmentapplication
- Methods And Compounds For Modulating Immune Responseapplication
- Methods And Compounds For Modulating Immune Responseapplication
- Compounds, Compositions, And Methods For The Treatment Of Metabolic Diseaseapplication
- Withaferin A Analog And Method For Treatment Using The Sameapplication
- Mass-targeted Fractionation System With Asynchronous Dual-dimension Separationapplication
- Multi-omic Patient Stratification In Inflammatory Bowel Disease Treatmentapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.